Pure Global AI
NCT06319716Not yet recruiting

Leveraging Videos and Community Health Workers to Address Social Determinants of Health in Immigrants

LINK-IT: Leveraging Videos and Community Health Workers to Address Social Determinants of Health in Immigrants
NYU Langone HealthClinicalTrials.govbehavioral
Study focus
Disease/Condition
Type 2 Diabetes
Drug/Device/Intervention
Video-Based Diabetes Self-Management Education and Support (DSMES)
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
NYU Langone Health
Location
New York, United States of America
Timeline & enrollment
Phase
N/A
Start date
Jun 01, 2024
End date
Jun 30, 2028
Enrollment
324 participants
Primary outcome

Hemoglobin A1c (HbA1c) Levels,Hemoglobin A1c (HbA1c) Levels,Hemoglobin A1c (HbA1c) Levels

Summary

The overall goal of this study is to examine the efficacy of the video-based Diabetes
 Self-Management Education and Support (DSMES) (hereafter VIDEO), or the video-based
 DSMES+community health worker (CHW) intervention (hereafter VIDEO+CHW), compared with a
 wait-list control group (hereafter CONTROL) to improve glycemic control among Chinese
 immigrants with uncontrolled Type 2 diabetes in NYC.

ICD-10 classifications
Type 2 diabetes mellitusType 2 diabetes mellitus without complicationsType 2 diabetes mellitus with unspecified complicationsType 2 diabetes mellitus with other specified complicationsType 2 diabetes mellitus with multiple complications
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06319716
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06319716 through Pure Global AI's free database. This phase not specified trial is sponsored by NYU Langone Health and is currently Not yet recruiting. The study focuses on Type 2 Diabetes. Target enrollment is 324 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.